Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going

Lymphangioleiomyomatosis (LAM), a multisystem disease affecting predominantly premenopausal and middle-aged women, causes progressive respiratory failure due to cystic lung destruction and is associated with lymphatic and kidney tumors. In the past, the treatment of LAM comprised exclusively anti-es...

Descripción completa

Detalles Bibliográficos
Autores principales: Taveira-DaSilva, Angelo M, Steagall, Wendy K, Moss, Joel
Formato: Texto
Lenguaje:English
Publicado: Medicine Reports 2009
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948329/
https://www.ncbi.nlm.nih.gov/pubmed/20948684
http://dx.doi.org/10.3410/M1-93

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948329/
https://www.ncbi.nlm.nih.gov/pubmed/20948684
http://dx.doi.org/10.3410/M1-93

Ejemplares similares